Impurities are an inherent part of the manufacture of pharmaceuticals, cosmetics, medical devices, and industrial chemicals. They may arise from raw materials, synthesis processes, degradation, or storage conditions. Although often present at trace levels, their toxicological significance cannot be underestimated.
Regulatory authorities such as the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), the U.S. Food and Drug Administration (USFDA), the European Medicines Agency (EMA), and the European Chemical Agency (ECHA) emphasize a science-based toxicological risk assessment of impurities to ensure they remain within toxicologically acceptable limits. The core principle is simple yet critical: the safety of a product depends not only on what is intentionally added, but also on what is unintentionally present.
Types and Source of Impurities
Impurities are broadly classified based on their origin and chemical nature.
- Organic Impurities
Arise from synthesis, formulation, or degradation.
Examples: starting material residues, intermediates, by-products, degradation products.
- Inorganic Impurities
Derived from reagents, catalysts, or manufacturing processes or equipment.
Examples: heavy metals, residual catalysts, inorganic salts, processing aids.
- Residual Solvents
Inorganic or organic chemicals are used during the synthesis, purification, or formulation of a drug substance. Their presence must be controlled based on toxicity classification, as outlined in ICH Q3C.
- Degradation Products
Formed during product shelf life, environmental factors such as heat, light, moisture, oxidation, or pH changes.
- Extractables and Leachables
Packaging materials, container closure systems, and processing equipment may introduce unintended substances into the product. These extractables and leachables must be assessed, particularly for products with prolonged contact or chronic exposure scenarios.
Scientific Framework for Toxicological Risk Assessment
A structured toxicological risk assessment of impurities follows internationally accepted scientific principles. The objective is to determine whether an impurity poses a health risk at its anticipated exposure level.
The assessment is based on four core steps:
Hazard Identification
Dose–Response Assessment
Exposure Assessment
Risk Characterization
This risk-based framework ensures impurity limits are scientifically justified, toxicologically acceptable, and aligned with global regulatory expectations.